Search

The novel coronavirus, or COVID-19, emerged from Wuhan, Hubei Province, China, and has recently spread all over the world. During the COVID-19 pandemic, healthcare workers struggle against this microscopic enemy due to their job responsibilities, thus leading to be infected in some of them, even some of them are died in line of duty. As of 2 February 2021, 37 million cases of COVID-19 among health workers from 183 countries and regions were reported to the World Health Organization (WHO), a figure that represents 36% of the total cases globally. The median age of these cases was 42 years and 68% were women. On May 24, 2021, the World Health Organization (WHO) stated that at least 115,000 healthcare workers have died due to COVID-19 worldwide since the pandemic began last year. It is important to pay attention to the situation related to COVID-19 infection for medical staff and their preventive measures. This paper reviews the literature on all available information about the situation and preventive measures (The primary prevention of COVID-19 is to break the chain of transmission from infected to healthy people, secondary preventive measures comprise the use of health screening and recognition activities to ascertain those infected with COVID-19 and tertiary prevention consists of treatment and proper rehabilitation) related to COVID-19 infection for medical staff.

Arash Nemat,1– 3 Atiqullah Majeedi,2 Abdul Wahed Sediqi,2,4 Qingchun Zeng1 1Department of Cardiology, Nanfang Hospital, Southern Medical University, Guangzhou, People’s Republic of China; 2Department of Cardiology, Ariana Medical Complex, Kabul, Afghanistan; 3Department of Microbiology, Kabul University of Medical Sciences, Kabul, Afghanistan; 4Department of Cardiology, Ali Abad Teaching Hospital, Kabul University of Medical Sciences, Kabul, AfghanistanCorrespondence: Qingchun Zeng, Department of Cardiology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, People’s Republic of China, Email qingchunzeng@smu.edu.cn Arash Nemat, Department of Cardiology, Ariana Medical Complex, Kabul, Afghanistan, Email dr.arashnemat@yahoo.comAbstract: Myocardial bridge (MB) is a congenital coronary anomaly in which a portion of the coronary artery courses intramyocardium instead of the normal trajectory on the epicardial surface. We report a case study with a 44-year-old man from Faryab Province in Afghanistan who presented chest pain and dizziness while suffering a common cold. After full investigation, the patient underwent coronary angiography which showed a myocardial bridge at the middle portion of the left anterior descending artery (LAD) with a significant stenosis causing ischemia. We treated the patient with a calcium channel blocker as initial treatment. The patient tolerated the medication well and remained asymptomatic during two years follow-up.Keywords: myocardial bridge, coronary angiography, case report

Supplemental material, sj-docx-1-inq-10.1177_00469580221117743 for Public Perception and Preparedness to Fight Against the Third Wave of COVID-19 in Kabul, Afghanistan by Arash Nemat, Farah Yasmin, Mohammad Yasir Essar, Nahid Raufi, Shoaib Ahmad, Abdullah Asady and Qingchun Zeng in INQUIRY: The Journal of Health Care Organization, Provision, and Financing

Supplemental material, sj-docx-1-smo-10.1177_20503121221122399 for Self-reported adherence to preventive practices during the third wave of COVID-19 in Afghanistan by Arash Nemat, Mohammad Faiq Sediqi, Yasir Ahmed Mohammed Elhadi, Nahid Raufi, Mohammad Yasir Essar and Abdullah Asady in SAGE Open Medicine

Abdul Wahed Sediqi,1,2 Arash Nemat,3 Nahid Raufi,4 Abdullah Asady3 1Department of Cardiology, Ariana Medical Complex, Kabul, Afghanistan; 2Department of Cardiology, Ali Abad Teaching Hospital, Kabul University of Medical Sciences, Kabul, Afghanistan; 3Department of Microbiology, Kabul University of Medical Sciences, Kabul, Afghanistan; 4Department of Dermatology, Maiwand Teaching Hospital, Kabul University of Medical Sciences, Kabul, AfghanistanCorrespondence: Arash NematDepartment of Microbiology, Kabul University of Medical Sciences, 3rd District, Kabul, 1001, AfghanistanTel +93 706 717 987Email dr.arashnemat@yahoo.comAbstract: The COVID-19 is an ongoing global pandemic that has put the world in a devastating situation. The virus is able to attack multiple body systems and cause a variety of clinical problems ranging from asymptomatic to critical cases. Although young individuals are more likely to suffer milder forms of the disease, critical cases also might happen. Recent literature has revealed that, along with other clinical symptoms, skin manifestations have also progressively grown. In Afghanistan where COVID-19 has entered into a third wave, many people do not take the initial mild symptoms seriously to prevent further spreading in the community. We report symptoms of skin rash, fatigue, muscle pain, dry cough and fever at the onset of the disease, followed by rapid lung damage in a 23-year-old young adult, who did not have any preexisting risk factors. This case highlights the importance of urgent skin assessment of the COVID-19 patient complaining of any skin symptoms.Keywords: COVID-19, skin rash, SARS-CoV-2, Kabul, case report

Nahid Raufi,1,2 Arash Nemat3,4 1Department of Dermatology, Maiwand Hospital, Kabul University of Medical Sciences, Kabul, Afghanistan; 2Department of Dermatology, Guangdong Provincial Dermatology Hospital, Southern Medical University, Guangzhou, People’s Republic of China; 3Department of Microbiology, Kabul University of Medical Sciences, Kabul, Afghanistan; 4Department of Cardiology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, People’s Republic of ChinaCorrespondence: Arash NematDepartment of Microbiology, Kabul University of Medical Sciences, 3rd District, Jamal Mina, Kabul, 1001, AfghanistanTel +93 706 717 987Email dr.arashnemat@yahoo.comAbstract: Infantile hemangiomas (IHs) are the most common vascular tumors in childhood. We report the use of propranolol to treat the growth phase of IHs. Propranolol was given to a 6-month-old infant who presented with a 4-cm sharply demarcated hemangioma on his left gluteal region. After relevant evaluation, propranolol was prescribed with a starting dose of 1 mg/kg/day, given in 3 divided doses. Vital signs were monitored during the first 6 hours of treatment. In the absence of side effects, treatment was continued at home with 2 mg/kg/day for six months, and the child was reevaluated after 7 days of treatment and then monthly. After one month, effects on color and growth were noted. Complete healing occurred in less than 6 months. Side effects and relapse were not reported. Propranolol administered orally at 2 mg/kg/day was successful, leading to near resolution of the patient’s hemangioma.Keywords: hemangioma, infantile hemangioma, propranolol, vascular tumor, beta-blocker